|
JP2018199705A
|
|
Liposome, formulation containing liposome, and method for producing formulation
|
|
JP2017214395A
|
|
Liposome, formulation containing liposome, and method of producing formulation
|
|
WO2015175866A1
|
|
Use of bisphosphonates as hiv/aids adjunctive treatment
|
|
CN105188674A
|
|
Liposome formulation and manufacture
|
|
US2014271813A1
|
|
Liposome formulation and manufacture
|
|
EP2279726A2
|
|
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
|
WO2005044175A2
|
|
Desensitization of complement activation using monocyte/macrophage inhibitory compounds
|
|
WO2005002545A1
|
|
Method of treating acute coronary syndromes
|
|
US7048714B2
|
|
Drug eluting medical device with an expandable portion for drug release
|
|
AU2002341248A1
|
|
Method of delivering drugs to a tissue using drug-coated medical devices
|
